Partners News ATRO Medical closes a new financing round for the Trammpolin meniscus prosthesis
17 December 2021

ATRO Medical, a Radboudumc and DSM spin-off, is based in Uden and has an office in Nijmegen, where the company benefits from the expertise and facilities of Radboudumc. Jan Hunik, co-founder and CEO: "I am very pleased with this investment round and welcomes the trust in the Trammpolin® device at this stage of the development. The funds raised will enable the company to execute a second clinical study to demonstrate its potential to improve the quality of lives of patients".

Read the full article on ATRO Medical

image courtesy of ATRO Medical

Related news items


EU grant awarded to development of meniscus prosthesis € 2.5 million for ATRO Medical

8 June 2022 The Dutch startup works on the first anatomical meniscus prostheses for patients with chronic knee pain. Their ground-breaking innovation continues to attract international attention, paving the way towards full-scale healthcare implementation. read more

Radboudumc and Terumo Europe N.V. sign collaboration agreement

3 June 2022 Together, the two partners will improve existing treatments for cancer patients and develop new, personalized therapies. Focus will be on the clinical use of holmium-166 microspheres, small radioactive beads. read more

More accurate surgery with the Anatomy Projector

30 May 2022 The Anatomy Projector, developed at the Radboudumc, allows surgeons to operate much more accurately with projected augmented reality. read more

Investment in ARNE helps neonatologists make better decisions when treating newborn babies

28 April 2022 ARNE B.V. has raised financing from Oost NL and venture builder NLC. ARNE supplies smart software with which neonatologists can make decisions based on data after the birth of a child. read more

Survey of patients to address knee pain from removed meniscus

19 November 2021 Patients with persistent knee pain after meniscus removal can participate at three locations in the Netherlands in the AIR2 study by ATRO Medical, a spin-off of the Radboudumc and DSM. read more